{"id":"W2079589100","doi":"10.1016/j.critrevonc.2009.08.005","title":"Treatment for metastatic malignant melanoma: Old drugs and new strategies","year":2009,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Directorate for Biological Sciences","keywords":"Medicine; Dacarbazine; Melanoma; Metastatic melanoma; Immunotherapy; Clinical trial; Oncology; Chemotherapy; First line; Refractory (planetary science); Cancer; Internal medicine; Cancer research","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008328406,0.0009940658,0.002157735,0.001696681,0.0003396798,0.001052406,0.001138894,0.001283807,0.003211121],"category_scores_gemma":[0.0007668377,0.0003014202,0.0006609018,0.001421217,0.0007271023,0.00174481,0.0005936688,0.002990949,0.00188441],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006814756,"about_ca_system_score_gemma":0.0007929497,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001002928,"about_ca_topic_score_gemma":0.002733147,"domain_scores_codex":[0.9997719,0.00004713705,0.00002522035,0.00004099519,0.00009301059,0.00002175441],"domain_scores_gemma":[0.9996409,0.0001900717,0.00004095176,0.00001256986,0.00008415747,0.00003125812],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001212358,0.0001065191,0.0001169364,0.006730667,0.00009864628,0.0001992561,0.0000353472,0.0004169655,0.001465168,0.002519984,0.05531007,0.9328793],"study_design_scores_gemma":[0.0000911512,0.0001847812,0.000527711,0.002467933,0.0001633485,0.001205615,0.00005058343,0.0001996654,0.0004524263,0.002029968,0.9926052,0.00002168014],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008649241,0.9983437,0.0001417494,0.0005013267,0.0003263857,0.000004556928,0.000009673642,0.000006768397,0.0005794261],"genre_scores_gemma":[0.0006656307,0.9975569,0.0002578187,0.0005629819,0.000396592,0.000007587531,0.00002172642,0.000002044179,0.0005286463],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003211121,"threshold_uncertainty_score":0.01074225,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2065223788696071,"score_gpt":0.5077436865363419,"score_spread":0.3012213076667348,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}